ORIC | ORIC PHARMACEUTICALS INC

CUSIP: 68622P109

0 Funds Holding

0 Total Shares

$0 Total Value

$983M

Market Cap

—

P/E Ratio

-6.4

Forward P/E

$-1.71

EPS (TTM)

—

Dividend Yield

$287M

Cash

$3M

Total Debt

97M

Shares Out

$3.90

$14.93

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
No funds currently hold this stock.

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2025-Q1
Viking Global Investors	BUY	+48.3%	6.6M	$37M	$8.26
2024-Q4
Viking Global Investors	BUY	+10.8%	4.4M	$36M	$9.38
2024-Q1
Viking Global Investors	BUY	NEW	4.0M	$55M	$11.52

6 Months Insider Sentiment

100%

Buy $0 Sell $3.5M

0 Buys

8 Sells

-3.5M Net

0 Grants

Largest

$1.3M Chacko

$639K Chacko

$462K Chacko

Date	Insider Click to search	Role Click to search	Type	Shares	Price	Value
Dec 16, 2025	Dominic Piscitelli	Chief Financial Officer	SELL	10.7K	$9.06	$97K
Dec 16, 2025	Jacob Chacko	PRESIDENT AND CEO	SELL	33.4K	$9.06	$302K
Dec 16, 2025	Pratik S Multani	Chief Medical Officer	SELL	10.7K	$9.06	$97K
Dec 15, 2025	Dominic Piscitelli	Chief Financial Officer	EXERCISE	29.3K	—	—
Dec 15, 2025	Jacob Chacko	PRESIDENT AND CEO	EXERCISE	83.7K	—	—
Dec 15, 2025	Pratik S Multani	Chief Medical Officer	EXERCISE	29.3K	—	—
Dec 08, 2025	Lori Anne Kunkel	Director	EXERCISE	10.0K	$7.90	$79K
Oct 06, 2025	Dominic Piscitelli	Chief Financial Officer	EXERCISE	11.0K	$4.36	$48K
Oct 06, 2025	Dominic Piscitelli	Chief Financial Officer	SELL	11.0K	$14.52	$160K
Oct 06, 2025	Jacob Chacko	PRESIDENT AND CEO	SELL	37.5K	$12.32	$462K
Oct 03, 2025	Richard A. Heyman	Director	EXERCISE	1.4K	$3.75	$5K
Oct 03, 2025	Richard A. Heyman	Director	EXERCISE	31.4K	$1.60	$50K
Oct 01, 2025	Jacob Chacko	PRESIDENT AND CEO	SELL	53.0K	$12.05	$639K
Sep 30, 2025	Jacob Chacko	PRESIDENT AND CEO	SELL	34.5K	$12.01	$415K
Sep 22, 2025	Jacob Chacko	PRESIDENT AND CEO	SELL	125.0K	$10.80	$1.3M

Institutional Ownership of ORIC PHARMACEUTICALS INC